Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1998-7-10
|
pubmed:abstractText |
The mechanism of adenosine-induced inhibition of ganglionic transmission was investigated in the isolated superior cervical ganglion (SCG) of the rat. The inhibitory effect of adenosine on the postganglionic compound action potential (CAP) was antagonized by pretreatment of ganglia with forskolin, isoproterenol (IPNE), arginine vasopressin (AVP), or papaverine, all of which are known to increase tissue cAMP level by different mechanisms. Furthermore, pretreatment of ganglia with the adenylate cyclase inhibitor SQ 22, 536, or the phosphodiesterase activator imidazole reversed the effects of IPNE and forskolin. Pretreatment with 8-bromo-cAMP, resulted in a marked antagonism of the adenosine-induced inhibition. By themselves, none of these drugs had any significant effect on the CAP. Adenosine slightly but significantly decreased the basal level of cAMP in untreated ganglia. Formation of cAMP induced by IPNE was markedly reduced by adenosine. This was largely reversed in the presence of the adenosine A1 receptor antagonist 8-cyclopentyl-1, 3-dipropylxanthine (DPCPX) but not the A2 receptor antagonist 3, 7-dimethyl-1-propargylxanthine (DPMX). We conclude that the inhibition of ganglionic transmission by adenosine involves reduction of cAMP formation through activation of A1 receptors.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/3',5'-Cyclic-AMP Phosphodiesterases,
http://linkedlifedata.com/resource/pubmed/chemical/Adenosine,
http://linkedlifedata.com/resource/pubmed/chemical/Adenylate Cyclase,
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Ganglionic Blockers,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphodiesterase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Vasopressins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0006-8993
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 1998 Elsevier Science B.V.
|
pubmed:issnType |
Print
|
pubmed:day |
23
|
pubmed:volume |
787
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
242-7
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9518635-3',5'-Cyclic-AMP Phosphodiesterases,
pubmed-meshheading:9518635-Adenosine,
pubmed-meshheading:9518635-Adenylate Cyclase,
pubmed-meshheading:9518635-Adrenergic beta-Agonists,
pubmed-meshheading:9518635-Animals,
pubmed-meshheading:9518635-Cyclic AMP,
pubmed-meshheading:9518635-Enzyme Activation,
pubmed-meshheading:9518635-Enzyme Inhibitors,
pubmed-meshheading:9518635-Ganglionic Blockers,
pubmed-meshheading:9518635-Male,
pubmed-meshheading:9518635-Phosphodiesterase Inhibitors,
pubmed-meshheading:9518635-Rats,
pubmed-meshheading:9518635-Rats, Sprague-Dawley,
pubmed-meshheading:9518635-Superior Cervical Ganglion,
pubmed-meshheading:9518635-Synaptic Transmission,
pubmed-meshheading:9518635-Vasopressins
|
pubmed:year |
1998
|
pubmed:articleTitle |
Cyclic AMP antagonizes adenosine-induced inhibition of ganglionic transmission.
|
pubmed:affiliation |
Department of Biology, Texas Southern University, Houston, TX 77004, USA.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, U.S. Gov't, P.H.S.
|